# Japan FFRangio Clinical Outcomes Study

> **NCT05648396** · — · ACTIVE_NOT_RECRUITING · sponsor: **Rabin Medical Center** · enrollment: 2500 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **OTHER:** FFRangio

## Key facts

- **NCT ID:** NCT05648396
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-07
- **Primary completion:** 2024-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2022-12-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05648396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05648396, "Japan FFRangio Clinical Outcomes Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05648396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*